Do Analysts Think Akebia Therapeutics Inc (AKBA) Is Still Worth Buying In 2025?

Akebia Therapeutics Inc (NASDAQ:AKBA) does about 2.39M shares in volume on a normal day but saw 1611574 shares change hands in the recent trading day. The company now has a market cap of 519.27M USD. Its current market price is $2.38, marking a decrease of -0.42% compared to the previous close of $2.39. The 52 […]